SECsense Logo

Portage Biotech Inc. 6-K Report: Nasdaq Compliance Plan Accepted

$PRTG
Form 6-K
Filed on: 2025-02-12
Source
Portage Biotech Inc. 6-K Report: Nasdaq Compliance Plan Accepted

Here are the key insights extracted from the provided section of Portage Biotech Inc.'s financial report (Form 6-K):

  1. Filing Details:
  • Form Type: 6-K (Report of Foreign Private Issuer)
  • Filing Date: February 12, 2025
  • Commission File Number: 001-40086
  1. Company Information:
  • Company Name: Portage Biotech Inc.
  • Address: Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
  1. Compliance Notification:
  • The company received a notification from The Nasdaq Stock Market, LLC indicating that Nasdaq has accepted its compliance plan.
  • Portage Biotech has been granted an extension to regain compliance with Nasdaq’s minimum shareholders’ equity requirement for continued listing on The Nasdaq Capital Market.
  1. Incorporation by Reference:
  • The report is to be incorporated by reference into the registration statement on Form S-8 (File No. 333-275842).
  1. Exhibit:
  • The report includes a press release dated February 12, 2025, as Exhibit 99.1, which contains further details regarding the compliance plan acceptance.
  1. Signatory Information:
  • The report is signed by Andrea Park, Chief Financial Officer of Portage Biotech Inc.

This information highlights the company's ongoing compliance efforts with Nasdaq listing requirements, which is critical for investors and stakeholders monitoring its financial health and operational status.